Alerts will be sent to your verified email
Verify Email
UNICK
|
Unick Fix-A-Form
|
Guj. Terce Lab
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.15 % | -11.74 % | 3.34 % |
|
5yr average Equity Multiplier
|
2.49 | 3.3 | 1.75 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 1.76 | 0.81 |
|
5yr Avg Net Profit Margin
|
4.16 % | -2.57 % | 2.69 % |
|
Price to Book
|
1.08 | 5.56 | 0.0 |
|
P/E
|
14.13 | 0.0 | 170.81 |
|
5yr Avg Cash Conversion Cycle
|
21.15 Days | -20.6 Days | 147.94 Days |
|
Inventory Days
|
48.34 Days | 40.01 Days | 58.04 Days |
|
Days Receivable
|
79.56 Days | 39.02 Days | 130.3 Days |
|
Days Payable
|
119.31 Days | 100.7 Days | 44.85 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 1.07 | 1.79 |
|
5yr Avg ROCE
|
12.8 % | 3.46 % | 9.64 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | -0.49 % | 9.07 % |
|
5 yr average Debt to Equity
|
0.86 | 0.63 | 0.57 |
|
5yr CAGR Net Profit
|
-7.47 % | -17.21 % | 0.0 |
|
5yr Average Return on Assets
|
3.64 % | -3.57 % | 1.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.57 % | 37.03 % | 63.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
35.92 % | 0.81 % | -0.63 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Unick Fix-A-Form
|
Guj. Terce Lab
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|